New Mexico
Register / Volume XXXVII, Issue 22 / November 17, 2026
This is an
amendment to 16.19.34 NMAC, Section 8 and 9 effective 11/17/2026.
16.19.34.8 PROCEDURES: Eligible
recipients must adhere to procedures for accepting and redistributing donated
prescription drugs, including refrigerated drugs, consistent with public health
and safety standards. Any person,
including persons from other states, may donate unexpired and unused prescription
drugs to an eligible recipient, and an eligible recipient may accept and
redistribute the donated prescription drugs in accordance with board
rules. An eligible recipient may
dispense or administer prescription drugs to a patient only if otherwise
permitted by law. Donated prescription
drugs shall only be redistributed to a patient if the drugs will not expire
before the patient is able to completely use the drugs, based on the directions
for use given by the patient's prescribing health care professional
A. Before accepting donated
prescription drugs the eligible recipient shall:
(1) register with the board as an eligible recipient;
(2) identify drug as eligible or ineligible prior to accepting the donated
drug into inventory;
(a) ineligible drugs may not be accepted for donation;
(b) single unit doses that consist of two or more
separately manufactured drug products may not be separated and repackaged. This
restriction does not apply to finished, manufactured combination drug products
that contain multiple active ingredients in a single dosage form;
(c) drugs packed in single unit doses may be
accepted and redistributed when the outside packaging is opened if the single
unit dose packaging is undisturbed;
(d) specialty medication delivered to a facility
or practitioner that cannot administer or distribute to the patient originally dispensed
for may be donated and redistributed if the medication was stored properly and
kept under restricted access to prevent tampering or adulteration.
B. Storage: Comply with
the manufacturer’s storage requirements per the drug monograph. An eligible
recipient practitioner may only store drugs at the board-registered address,
which may not be a mobile or home address.
C. Labeling prior to redistribution:
(1) Remove previous patient information.
(2) Comply with FDA and state labeling requirements.
D. Redistribution:
(1) Comply with all applicable federal and state laws that deal with the
inspection, storage, labeling and redistribution of donated prescription drugs.
(2) Examine the donated prescription drug to determine that it has not been
adulterated or misbranded and certify that the drug has been stored in
compliance with the requirements of the product.
(3) Have all patients receiving donated prescription drugs read and
electronically or physically sign the patient form.
(4) Prescription or order required:
(a) A
prescription is required for an eligible recipient pharmacy to dispense donated
prescription drug to a patient.
(b) A practitioner may redistribute donated prescription drug to their own
patient pursuant to a valid patient-practitioner relationship with records
maintained consistent with the standard of care and as required by this Part. A practitioner may not redistribute donated
prescription drugs to themselves.
(5) Comply with all applicable REMS requirements, including:
(a) registration
and reporting;
(b) provide patient with MedGuide
or PPI;
(6) Redistributed drugs will be provided to the patient with
information on side effects, interactions, and precautions concerning the drug
or device provided. Patient information
will be written, or alternative forms of patient information may be used to
supplement patient counseling when appropriate.
Examples include, but not limited to, written information leaflets,
pictogram labels and video programs.
E. Inspection: Determine
that the donated prescription drugs are in tamper-evident packaging,
unadulterated, unexpired, and safe and suitable for redistribution.
(1) When inspecting packaging ensure:
(a) tamper-evident packaging is intact;
(b) there are no breaks, cracks or holes in packaging;
(c) consistency of information, such as expiration date and lot number on inner
and outer packaging, if applicable.
(2) When inspecting liquids observe, if possible, without removing tamper
evident primary container seal:
(a) color;
(b) thickness;
(c) unusual particles;
(d) transparency;
(e) odor.
(3) When inspecting tablets or capsules observe and confirm uniformity, if
possible, without removing tamper evident primary container seal:
(a) color;
(b) shape;
(c) unusual spots;
(d) texture;
(e) odor;
(f) imprint or markings;
(g) physical damage, cracks, breaks, erosion, abrasion.
F. Payment, handling fee: A
handling fee not to exceed the reasonable costs of participating in the
collection of donated prescription drugs may be charged to the patient by the
eligible recipient to cover the costs of inspecting, storing, labeling and
redistributing the donated prescription drug.
Prescription drugs donated under this Part shall not be resold, and
donors may be reimbursed only for reasonable, donation-related costs, including
shipping and logistics.
G. Interstate
Participation: A properly licensed
eligible recipient pharmacy operating in another state may participate in the
activities described under this Part and may dispense donated drugs to patients
in this state in compliance with state and federal laws, unless compliance
would violate the laws of the resident state.
H. Transfer
and Repackaging: Notwithstanding any
other law or rule, an eligible recipient pharmacy may:
(1) Transfer donated prescription drugs to another eligible recipient
pharmacy. The receiving pharmacy must
maintain records of the transfer. Any
subsequent transfer of a donated prescription drug must include pedigree
records tracing to the original eligible recipient. The transferring pharmacy may assess a
handling fee not to exceed the reasonable costs of transferring the drug.
(2) Repackage donated prescription drugs as necessary for storage, dispensing,
administration, or transfers in accordance with this Part.
(3) Repackaged
prescription drugs shall be labeled with the drug name, strength, and
expiration date. If multiple packaged
donated prescription drugs with varied expiration dates are repackaged together
for dispensing, the shortest expiration date shall be used.
I. An
eligible recipient that engages in sales or other monetary transactions for
prescription drugs shall keep donated drug inventory in a manner that distinguishes
them physically or electronically from non-donated inventory.
J. The
donation, transfer, receipt or facilitation of donation, transfer, and receipt
of prescription drugs under this Part is not wholesale distribution and shall
not require a wholesale distributor license.
[16.19.34.8 NMAC - Rp,
16.19.34.8, 2/10/2026; A, 11/17/2026]
16.19.34.9 RECORD
KEEPING: Eligible recipients shall maintain records of
receipt and redistribution for three years.
A. Receipt records:
(1) donor verification that the prescription drug is voluntarily donated, was
properly stored, the container has not been opened or tampered with, and the
drug has not been adulterated or misbranded;
(2) date of donation;
(3) name, address and telephone number of donor;
(4) name, strength and quantity of the drug;
(5) drug manufacturer;
(6) drug expiration
date;
B. Redistribution records, patient form:
(1) Prior to the initial dispensing of a donated prescription
drug, a patient will electronically or physically sign a form that specifies:
(a) knowledge that the donor took reasonable care of the donated
prescription drug;
(b) knowledge that the donated prescription drug has been inspected and there is no
reason to believe that the donated prescription drug was improperly handled or
stored;
(c) that any person who exercises reasonable care in donating, accepting or
redistributing pursuant to Section 26-1-3.2 NMSA 1978 shall be immune from
civil or criminal liability or professional disciplinary action of any kind for
any related injury, death or loss;
(d) that the immunity provided by Section 26-1-3.2 NMSA 1978 shall not
decrease or increase the civil or criminal liability of a drug manufacturer,
distributors or dispenser that would have existed but for the donation;
(2) Patients receiving donated prescription drugs from an eligible recipient
that predominantly dispenses donated prescription drugs shall be required to
sign the form only at their initial dispense.
C. Redistributed
drugs administered, dispensed or distributed:
(1) An eligible recipient practitioner will maintain records including:
(a) patient name, date of birth
(b) drug name, strength, dosage form, quantity, and
expiration date;
(c) date administered, dispensed, or distributed;
(2) These records will be maintained for three years, and available
for inspection by the board.
(3) An eligible recipient clinic
will maintain records as required by federal and state law, including 16.19.10
NMAC.
(4) An eligible recipient
pharmacy will maintain records as required by federal and state law, including
16.19.6 NMAC.
[C.] D. Custodial care facility, licensed facility
or clinic as donor:
(1) A custodial care facility or licensed facility as defined in 16.19.11.7
NMAC, or clinic as defined in 16.19.10.7 NMAC that engages in donation shall maintain
records that include:
(a) date of donation;
(b) entity the drug was donated to;
(c) patient name, as applicable;
(d) drug name, strength, dosage form, and quantity;
(e) date dispensed, as applicable;
(f) prescription number, as applicable;
(g) dispensing
pharmacy name, as applicable
(2) This record will be maintained for three years.
(3) The consultant pharmacist will be responsible for donation oversight.
[D.] E. A donor or eligible recipient may contract with one
another or a third-party to create or maintain records on each other’s
behalf. An identifier, such as a serial
number or barcode, may be used in place of any or all information required by a
record or label under this section if it allows for such information to be
readily retrievable. Upon request by a
state or federal regulator the identifier used for requested records shall be
replaced with the original information.
An identifier shall not be used on patient labels when dispensing or
administering a drug.
[E.] F. All records and
forms required by this Section may be in electronic form.
[F.] G. All records required under this part will be
available for inspection by the Board.
[16.19.34.9 NMAC - Rp,
16.19.34.9, 2/10/2026; A, 11/17/2026]